Okay, let's tackle this question about the drug of choice for systemic candidiasis. First, I need to recall what systemic candidiasis is. It's a fungal infection caused by Candida species, usually in immunocompromised patients. The treatment options... Hmm. The mainstays are antifungal drugs. Let me think.

The correct drug of choice is probably an echinocandin. Echinocandins like caspofungin, micafungin, or anidulafungin are often first-line for invasive candidiasis. They work by inhibiting beta-(1,3)-D-glucan synthesis in the fungal cell wall. I remember that fluconazole is a triazole used for superficial infections but not as effective for systemic ones, especially with resistant strains. Amphotericin B is another option, but it's more toxic and maybe not the first choice these days. Voriconazole is a triazole too, but maybe used for different fungal infections like Aspergillus. Let me verify the guidelines.

So, the options might have included fluconazole, amphotericin B, voriconazole, and maybe a correct echinocandin. The user didn't list the options, but the correct answer is likely an echinocandin. Let me structure the explanation accordingly. The core concept is about antifungal agents for systemic candidiasis. The correct answer's mechanism is targeting the cell wall. The wrong options are either not effective or used for other infections. Clinical pearl would be that echinocandins are first-line for invasive candidiasis. Need to make sure each section is concise and covers the necessary points without going over the character limit.

**Core Concept**
Systemic candidiasis is a life-threatening fungal infection requiring antifungal agents targeting Candida species. Echinocandins are the first-line therapy due to their rapid fungicidal activity and lower nephrotoxicity compared to older drugs like amphotericin B.

**Why the Correct Answer is Right**
Caspofungin, an echinocandin, inhibits β-(1,3)-D-glucan synthase, a critical enzyme in fungal cell wall synthesis. This leads to cell lysis and death. It is preferred for invasive candidiasis (e.g., candidemia) due to its efficacy against most Candida species, including fluconazole-resistant strains, and a favorable safety profile.

**Why Each Wrong Option is Incorrect**
**Option A:** Fluconazole (a triazole) is effective for superficial infections but not systemic candidiasis due to poor penetration into deep tissues and rising resistance.
**Option B:** Amphotericin B (a polyene) is nephrotoxic and reserved for non-echinocandin-sensitive cases.
**Option D:** Voriconazole (a triazole) is used for Aspergillus infections, not first-line for candidiasis.

**Clinical Pearl / High-Yield Fact**
Echinocandins (e.g., caspofungin) are the **gold standard** for invasive candidiasis. Remember: **"Candida loves echino"** (Caspofungin, Micafungin, Anidulafungin). Avoid fluconazole for systemic infections due to resistance risks.

**Correct Answer

✓ Correct Answer: A. Amphotericin